Studies have shown that the average time between initiation of TNF inhibitor therapy and the occurrence of a herpes zoster event of 8–19 months, with incidence peaking in the first 2 years after initiating biologic therapy (Zisman et al., 2016). Here, TNF is linked to herpes zoster.